{"gao_id": "GAO-09-245", "published": "2009-02-20T13:00:00Z", "released": "2009-03-23T09:00:00Z", "summary": "", "title": "Nonprescription Drugs: Considerations Regarding a Behind-the-Counter Drug Class", "topics": ["Foreign governments", "Locally administered programs", "Sales", "Safety regulation", "Public health", "Prescription drugs", "Import restriction", "Critical infrastructure", "Foreign policies", "Drugs", "Health care programs", "Cost control", "Pharmaceutical industry", "Substance abuse treatment", "Health care costs", "Health Care", "Consumer protection", "Cost awareness", "Product evaluation", "Pharmacological research", "Safety standards", "Medicare"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-09-245", "versions": [{"title": "Highlights", "url": "https://www.gao.gov/assets/gao-09-245-highlights.pdf"}, {"title": "Full Report (59 pages)", "url": "https://www.gao.gov/assets/gao-09-245.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/a286263.html"}]}